Canada markets close in 4 hours 42 minutes

Acasti Pharma Inc. (ACST)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
2.9650+0.1250 (+4.40%)
As of 10:47AM EDT. Market open.
Currency in USD

Valuation Measures4

Market Cap (intraday) 26.79M
Enterprise Value 1.70M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)0.41
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -0.14

Trading Information

Stock Price History

Beta (5Y Monthly) 1.52
52-Week Change 37.95%
S&P500 52-Week Change 323.57%
52 Week High 33.8400
52 Week Low 31.7200
50-Day Moving Average 33.2858
200-Day Moving Average 32.6091

Share Statistics

Avg Vol (3 month) 326.18k
Avg Vol (10 day) 38.05k
Shares Outstanding 59.4M
Implied Shares Outstanding 69.4M
Float 86.29M
% Held by Insiders 116.02%
% Held by Institutions 112.13%
Shares Short (Apr 15, 2024) 43.82k
Short Ratio (Apr 15, 2024) 40.12
Short % of Float (Apr 15, 2024) 40.05%
Short % of Shares Outstanding (Apr 15, 2024) 40.04%
Shares Short (prior month Mar 15, 2024) 46.59k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:6
Last Split Date 3Jul 10, 2023

Financial Highlights

Fiscal Year

Fiscal Year Ends Mar 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-7.92%
Return on Equity (ttm)-48.05%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -12.21M
Net Income Avi to Common (ttm)-38.77M
Diluted EPS (ttm)-5.6800
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)25.11M
Total Cash Per Share (mrq)2.67
Total Debt (mrq)24k
Total Debt/Equity (mrq)0.04%
Current Ratio (mrq)15.19
Book Value Per Share (mrq)6.88

Cash Flow Statement

Operating Cash Flow (ttm)-13.57M
Levered Free Cash Flow (ttm)-7.84M